Interstitial fluid glucose measurement

Interstitial fluid glucose measurement" is **not a molecule, receptor, enzyme, transporter, or other canonical therapeutic target**. Instead, it refers to the process of measuring **glucose concentration in the interstitial fluid (ISF)**—the fluid that surrounds cells beneath the skin—using sensor-based technologies such as continuous glucose monitoring systems (CGMs)[2][3][4]. These sensors are inserted subcutaneously and provide real-time data on ISF glucose levels for diabetes management. There is a physiological delay (typically 5–10 minutes) between changes in blood glucose and corresponding changes in ISF due to the time required for equilibration between compartments[1][3][7]. This method enables less invasive and more frequent monitoring compared to traditional fingerstick capillary blood measurements but does not represent a druggable biological target itself. **Summary:** "Interstitial fluid glucose measurement" describes a clinical technique/technology rather than a molecular entity or therapeutic target. It should not be classified as a receptor, enzyme, transporter, etc., making it an incorrect entry if used as such.

Other names

Interstitial glucose measurementISF glucose monitoring